Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
Frontiers in Neurology|June 10, 2026
Risk factors for disease generalization in acetylcholine receptor antibody-positive ocular myasthenia: a multicenter retrospective studyLorenzo Verriello, Roberto Sartor, Fabrizio Bellizzi, et al.
Transplantation Proceedings|October 15, 2019
Surgical Complications Requiring an Early Relaparotomy in HIV-Infected Liver Transplant Recipients: Risk Factors and Impact on SurvivalRiccardo Pravisani, Umberto Baccarani, Miriam Isola, et al.
Journal of Clinical Medicine|September 25, 2019
Autophagy and Inflammasome Activation in Dilated CardiomyopathyAngela Caragnano, Aneta Aleksova, Michela Bulfoni, et al.
Haematologica|April 12, 2008
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpuraFrancesco Zaja, Marta Lisa Battista, Maria Teresa Pirrotta, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 4, 2019
Early post-liver transplant surgical morbidity in HIV-infected recipients: risk factor for overall survival? A nationwide retrospective studyUmberto Baccarani, Riccardo Pravisani, Miriam Isola, et al.
Journal of Autoimmunity|November 16, 2013
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter studyLuca Quartuccio, Miriam Isola, Chiara Baldini, et al.
International Journal of Molecular Sciences|August 26, 2022
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker DiscoveryAntonio Paolo Beltrami, Maria De Martino, Emiliano Dalla, et al.
Rheumatology (Oxford, England)|September 5, 2022
Predicting lymphoma in Sjögren's syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recordingSalvatore De Vita, Miriam Isola, Chiara Baldini, et al.
Neuro-Oncology|December 12, 2017
An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cellsTamara Ius, Yari Ciani, Maria Elisabetta Ruaro, et al.
Blood|February 5, 2010
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopeniaFrancesco Zaja, Michele Baccarani, Patrizio Mazza, et al.
Pageof 19